The inanimate hospital environment has been identified as an important reservoir of nosocomial pathogens. 1, 2 The environment of a patient's room becomes contaminated especially in situations when patients suffer from infections with methicillin-resistant Staphylococcus aureus (MRSA) or vancomycin-resistant enterococci (VRE). Environmental cleaning has experienced a renaissance in recent years as a measure to reduce healthcare-acquired infections. 3 The role of routine surface disinfection of all parts of a hospital has been debated controversially in the past. 4 Routine surface disinfection has been recommended for high-risk settings. 5 Traditionally, aldehydes as broad-spectrum microbicides have been used for surface disinfection, especially in Europe. Glucoprotamin has been introduced as an active compound (AC) for aldehydefree disinfectants. 6 Unlike aldehydes, it does not evaporate, and it has shown good in vitro efficacy against multidrugresistant clinical strains 7 and has performed well in tests for medical instruments. 8 However, in-practice data for surface disinfection are lacking. Therefore, we initiated a crossover study to evaluate the effectiveness of Incidin (which contains glucoprotamin) relative to the current standard, Deconex (which contains aldehyde), in a high-risk clinical setting.
M E T H O D S Setting
The study was conducted at the hematologic transplant unit of the University Hospital Basel, Basel, Switzerland. Approximately 70 patients a year undergo stem-cell transplantation or high-dose chemotherapy with prolonged neutropenia, with an average stay of 4-6 weeks. Access is restricted. All rooms are single rooms and are provided with HEPA-filtered air, and healthcare workers wear protective clothing. The composition of the floor of the ward is PVC, and bathrooms are tiled. 
Study Design
The study was a prospective crossover study conducted from October through December 2010. The study unit was split into 2 equal parts: one part was disinfected using aldehydecontaining disinfectant (Deconex), while the other was allocated to a glucoprotamin-containing disinfectant (Incidin). The first part of the study lasted 4 weeks. Before switching products, a washout phase of 1 day was performed using a detergent. After this cleaning, the 2 disinfectants were used crossover for another 4 weeks.
Disinfectants and Disinfection Regime
The aldehyde-containing disinfectant (Deconex 50 FF; Borer Chemie) contained 12.0 g of glyoxal (ethanedial), 0.5 g of glutaraldehyde (pentanedial), and 7.5 g of didecyldimethylammoniumchloride per 100 g. The glucoprotamin-containing disinfectant (Incidin PLUS; Ecolab) contained 26 g of glucoprotamin per 100 g. The concentration recommended by the manufacturer for hospital use for a 1-hour exposure was 0.5%. The disinfectants were freshly prepared in the morning, and all touch surfaces and floors in the patient rooms were disinfected daily with the corresponding disinfectant. The unit has a designated cleaning staff, and the majority of the housekeeping personnel have been working for more than 5 years in this unit.
Hospital policy requires the use of a disinfectant active against spores when Clostridium difficile polymerase chain reaction ribotype 027 is isolated. 9 Rooms given this treatment were excluded from the study.
Sampling and Incubation
Sampling sites in rooms were as follows: the table used by staff (sample size, 10 x 10 cm), the electric bed control panel (whole surface, approximately 5 x 10 cm), the cold water faucet in the patient's bathroom (sphere, diameter of 5 cm), the table used by the patient (sample size, 10 x 10 cm), and the floor close to the patient's bed (sample size, 10 x 10 cm). Sampling was done every other day in the morning after disinfection. The time between disinfection and sampling was recorded. The sampling sites were swabbed with premoistened (0.9% NaCl) swabs (Unomedical). Swabs were vortexed in 2 mL of neutralizing solution, and 0.2 mL was plated on each medium.
The neutralizing solutions were validated for both disinfectants, and nontoxicity was proved. The following neutralizing solutions were used as recommended by the manufacturers: for Deconex (aldehyde), 3% Tween 80, 3% saponin, 0.1% histidine, and 0.1% cysteine; and for Incidin (glucoprotamin), 3% Tween 80, 3% saponin, 0.3% lecithin, 0.1% histidine, and 0.5% sodium thiosulfate.
Microbiology
The following media were used: Columbia agar (Becton Dickinson) with 5% sheep blood for total colony count, CHROMAgar orientation medium (Becton Dickinson) for gram-negative bacteria, BBL CHROMAgar S. aureus (Becton Dickinson), and Clostridium agar CLO (bioMerieux) for C. difficile. Incubation details were as follows: 36°C for 48 hours; for Columbia agar, C0 2 atmosphere; and for Clostridium agar, anaerobic conditions.
Molecular Typing
All strains of Pseudomonas aeruginosa, C. difficile, MRSA, and other multidrug-resistant pathogens were characterized by molecular typing (pulsed-field gel electrophoresis [PFGE]).
Statistical Analysis
Data were entered into a spreadsheet (Excel; Microsoft) and then imported into SPSS 19. Univariate analysis was performed using the x 2 test or the Fisher exact test, where appropriate, for categorical variables and the 2-tailed Student t test or the Kolmogorov-Smirnov test for continuous variables. Differences with P < .05 were regarded as statistically significant.
R E S U L T S
Of a total of 3,068 analyzed samples obtained, 1,528 were from surfaces disinfected with Deconex (AC aldehyde), and 1,540 were from surfaces disinfected with Incidin (AC glucoprotamin). One hundred fifty-two (9.9%) samples from aldehyde-disinfected surfaces and 185 (12.0%) samples from glucoprotamin-disinfected surfaces showed growth (P = .067). The bacterial counts on positive environmental sites were not statistically different (P -.58; Table 1 ) for both tested products.
Gram-negative bacteria were found in 1 sample (Enterobacter aerogenes), from a floor treated with Incidin (6 colonyforming units [CFUs]/100 cm 2 ). P. aeruginosa was found on a faucet. This strain was identical with a patient's isolate from rectal screening, confirmed by identical PFGE pattern. However, there was no evidence for P. aeruginosa infection.
S. aureus was isolated twice from floors disinfected with Deconex as well as twice from a floor, twice from a bed control panel, and once from a water faucet disinfected with Incidin. C. difficile was not detected in any samples, despite the fact that clinical cases occurred during the study and that selective culture medium was used.
Enterococci (E. faecalis and E. faecium) were the most frequently encountered pathogens, detected in 3% (glucoprotamin disinfection, n = 328) and 6% (aldehyde disinfection, n = 290) of all environmental samples (P -.14). High numbers (up to 8,000 CFUs/100 cm 2 ) of enterococci could be detected even shortly after disinfection (60 min).
D I S C U S S I O N
No significant difference in the antimicrobial effectiveness between the commonly used Deconex (AC aldehyde) and Incidin (AC glucoprotamin) was found ( 4 who postulated the need for disinfection of patients' environments more frequently than once daily. However, these studies did not use selective media to detect clinically important pathogens.
While it is obvious that the inanimate environment can be a source of nosocomial pathogens, clear guidance on the limits of microbial contamination of inanimate surfaces in hospital settings is lacking. Dancer 10 suggested a limit of less than 5 CFUs/cm 2 for frequent hand-contact surfaces in hospitals." In our study, we found results exceeding this limit even 60 minutes after disinfection, especially on the floor and on sites near patients (patient table and bed control panel).
Some limitations to this study should be mentioned. A standardization of sampling times was not feasible. However, our study design using multiple time points allowed us to show recontamination of the environment over time. Although patients are exposed to their environment 24 hours a day, routine surveillance could not document a clinical infection from the environmental source. In contrast, a patient infected with 5. aureus contaminated his environment in 3 samples (floor and bed control panel).
No gram-negative bacteria were detected from the environment, except for 1 strain of E. aerogenes. Of the positive clinical patient specimens obtained on the ward, 21% showed gram-negative bacteria (data not shown); however, we could not identify Escherichia coli or Klebsiella species from the environment. This might be due to the short survival times of some of the gram-negative bacteria 1 and to the stringent and thorough daily cleaning regimen.
One patient had toxin-positive C. difficile diarrhea during the study, potentially exposing the environment. 12 However, none of the environmental samples revealed C. difficile despite the use of selective culture medium. Neither disinfectant has sporicidal efficacy under the conditions applied in this study. A good subjective cleaning efficacy of both products was reported by the cleaning staff and in combination with the stringent and thorough daily cleaning regimen may have contributed to the absence of C. difficile. In fact, thorough cleaning without a disinfectant can remove more than 95% of spores. 1013 However, these data call into question whether sporicidal activity is required in a nonepidemic setting, 14 and further research would certainly be needed to explain these findings. 15 Enterococci were isolated from the environment even shortly after disinfection, as already observed by Weber and Rutala 16 and Anderson et al 17 for VRE. A stricter adherence to disinfection protocols was therefore recommended by Anderson et al. 17 VRE are becoming more and more problematic in hospitals and cause epidemic outbreaks, even though not all VRE are associated with outbreaks. 17 The frequent isolation of enterococci after disinfection may be due to recontamination or emergence of resistance to the disinfectant. In 3% of clinical specimens from the ward, enterococci were found; no VRE were reported during the study period (data not shown). We have tested 3 strains according to EN 1040, 18, 19 and no evidence for resistance to Deconex or Incidin was found. Similarly, Anderson et al 17 and Tyski et al 7 could show that VRE were susceptible to a spectrum of hospital-grade disinfectants, and they could not find a link between resistance to vancomycin and germicides.
In summary, the aldehyde-containing product and the glucoprotamin-containing product demonstrated similar efficacy against environmental contamination in a high-risk hospital environment, despite the use of selective media for C. difficile, S. aureus, and gram-negative bacteria in addition to standard medium. C. difficile was not detected even though glucoprotamin is not active against spores, possibly because of daily cleaning by in-house staff.
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